Page 137 - MSU Digital Book

31. Cheung AK, Rahman M, Reboussin DM, Craven TE, Greene T, Kimmel PL, et al.

Effects of intensive BP control in CKD. J Am Soc Nephrol. 2017;28:2812-23.
32. U.S. Food and Drug Administration. FDA approved drug products. [accessed 29
March 2020]. Available from: https://www.accessdata.fda. gov/scripts/cder/daf/.

33. Raebel MA. Hyperkalemia associated with use of angiotensin-converting enzyme
inhibitors and angiotensin receptor blockers. Cardiovasc Ther. 2012;30:e156-66.

34. NHS England, UK Renal Registry, Think Kidneys. “Sick day” guidance in patients at
risk of acute kidney injury: an interim position statement from the Think Kidneys
Board. Think Kidneys, 2015.

35. Kunz R, Friedrich C, Wolbers M, Mann JF. Meta-analysis: effect of monotherapy and
combination therapy with inhibitors of the renin angiotensin system on proteinuria

in renal disease. Ann Intern Med. 2008;148:30-48.
36. Lin YC, Lin JW, Wu MS, Chen KC, Peng CC, Kang YN. Effects of calcium channel
blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin

receptor blockers in patients with hypertension and chronic kidney disease
stage 3 to 5 and dialysis: a systematic review and meta-analysis. PLoS One. 2017

14;12:e0188975.
37. Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF. Aldosterone antagonists
for preventing the progression of chronic kidney disease: a systematic review and

meta-analysis. Clin J Am Soc Nephrol. 2009;4:542-51.
ั
ิ
ิ
ิ
�
ั
้
�
้
ั
้
ั
ั
38. แนวทำางเวช้ปฏิบื้ต้กี่ารู้ใช้ยารู้กี่ษาภูาวะไขมนผู้ดปกี่ต้เพอปองกี่นโรู้คหวใจและหลอดเลอด
ิ
ั
พ.ศึ. 2559. สมาคมโรู้คหลอดเล้อดแดงแหงปรู้ะเทำศึไทำย. เอพลสพรู้ิน.
�
่
39. Tatro D. Drug interaction facts. Wolters Kulwer Health. Missouri.US. 2014.
40. Su X, Zhang L, Lv J, Wang J, Hou W, Xie X, et al. Effect of statins on kidney disease
outcomes: a systematic review and meta-analysis. Am J Kidney Dis.2016;67:881-92.
41. Esmeijer K, Dekkers OM, de Fijter JW, Dekker FW, Hoogeveen EK. Effect of different
types of statins on kidney function decline and proteinuria: a network meta-
analysis. Sci Rep. 2019;9:16632.
42. Lin R, McDonald G, Jolly T, Batten A, Chacko B. A systematic review of prophylactic
anticoagulation in nephrotic syndrome. Kidney Int Rep. 2019;5:435-47.

112